A retrospective, real world study analysing Effectiveness of Hepatitis C Virus Treatment with Direct-Acting Antivirals in patients with existing advanced liver disease
Latest Information Update: 22 May 2020
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Glecaprevir/pibrentasvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 22 May 2020 New trial record
- 20 May 2020 Results presented at the 25th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 20 May 2020 Results presented at the 25th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research